(Q42986429)

English

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment

scientific article published on January 2009

Statements

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment (English)
Andreas Erhardt
Katja Deterding
Yves Benhamou
Markus Reiser
Xavier Forns
José Luis Calleja
Susanne Ross
Hans Christian Spangenberg
Javier Garcia-Samaniego
Michael Fuchs
Jaime Enríquez
Johannes Wiegand
Jerry Stern
Kate Wu
Pierre Beaulieu
Gerhard Nehmiz
Jürgen Steffgen
BILB 1941 Study Group
1 January 2009
23-32

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit